Neglected tropical diseases

Emodepside Challenges Ivermectin’s Dominance: Phase 2a Trial Reveals Highly Effective New Treatment for Strongyloidiasis

A landmark phase 2a trial in Laos identifies emodepside as a highly effective, weight-independent treatment for Strongyloides stercoralis, achieving cure rates of 89% at a 15 mg dose, matching the current gold standard ivermectin with a rob

The Silent Threat of Chagas Disease: Understanding the ‘Kissing Bug’ Epidemic in the U.S.